Company Profile
CONMED Stock Price, News & Analysis
- Ticker:
- CNMD
- Exchange:
- NYSE
- Sector:
- Biopharma
- Location:
- United States
Stock performance
49.77 USD (+0.95%)
Close
Last updated: August 6, 2026
1.02B USD
Market cap
Why the stock is moving
As of Aug 6, 2026, CNMD closed up 0.95% at $49.77. No new same-company headline was identified in the current news window.
Company overview
Business overview
CONMED is a surgical device company with products spanning endoscopy, orthopedics, and energy-based surgical systems.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NYSE, CONMED sits in procedure-driven medtech.
Business Model Characteristics
Revenue comes from surgical devices, recurring consumables, and hospital adoption across multiple specialties.
Position Within the Biotechnology Landscape
CONMED is a steady medtech name that trades on product launches and hospital demand rather than biotech catalysts.
Future catalysts
CONMED's catalysts are AirSeal adoption, arthroscopy demand, and continued execution in surgical devices and endoscopy. The next update matters because the company needs a cleaner product mix and steady procedure growth.
Recent news
- 01
CONMED Corporation Announces Management Transitions
Source: CONMED
- 02
- 03
- 04
- 05
CONMED Corporation Issues Open Letter to Shareholders
Source: CONMED
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of CONMED (CNMD)?
CONMED (CNMD) most recently closed at 49.77 USD, a +0.95% move versus the previous session.
What is the market cap of CONMED (CNMD)?
CONMED currently has a market capitalization of 1.02B USD on BioPharmSignal.
What does CONMED do?
CONMED is a surgical device company with products spanning endoscopy, orthopedics, and energy-based surgical systems.
On which exchange is CNMD stock listed?
CONMED (CNMD) is associated with NYSE, United States, Biopharma.
What is AirSeal?
CONMED's catalysts are AirSeal adoption, arthroscopy demand, and continued execution in surgical devices and endoscopy.
Which conditions is CONMED targeting with AirSeal?
CONMED's catalysts are AirSeal adoption, arthroscopy demand, and continued execution in surgical devices and endoscopy.
How does CONMED describe recent progress with AirSeal?
CONMED's catalysts are AirSeal adoption, arthroscopy demand, and continued execution in surgical devices and endoscopy.
What future catalysts are investors watching for CONMED?
CONMED's catalysts are AirSeal adoption, arthroscopy demand, and continued execution in surgical devices and endoscopy. The next update matters because the company needs a cleaner product mix and steady procedure growth.